A new approach in acute myeloid leukemia (AML): Samatya-predicting score

Area of Science:

• Hematology
• Oncology
• Clinical Prediction Models

Background:

• Acute myeloid leukemia (AML) necessitates accurate prognostic tools for treatment planning.
• The
• Samatya-predicting score
• was developed to assess prognosis and treatment response in non-acute promyelocytic leukemia (non-APL) AML cases.

Observation:

• A study evaluated 158 non-APL AML patients diagnosed between 2010 and 2020.
• The median risk score was 2.5.
• Overall survival (OS) was observed to be shorter in patients with higher risk scores.

Findings:

• The Samatya-predicting score demonstrated 88% sensitivity and 42% specificity for predicting mortality.
• For predicting non-response to induction therapy, the score achieved 90.1% sensitivity and 25.3% specificity.

Implications:

• This score offers a novel approach to predicting prognosis in AML, potentially guiding clinical decisions.
• Further validation may enhance its utility in managing non-APL AML patients.
• The findings contribute to developing personalized treatment strategies for AML.